Payment of annual retention fees for registered products

The Medicines and Related Substances Act, 1965 (Act 101 of 1965) as amended, (“the Medicines Act”) makes provision for the payment of retention fees to the Regulatory Authority in respect of medicines, medical devices and IVDs registered and site licences issued. Further to the above, Regulation GNR 784 as published in the Government Gazette 42474 dated 22 DECEMBER 2020 read in conjunction with the Medicines Act, states that : The following fees shall be paid to the Chief Executive Officer:

2022 May